CN101596246A - 乌梅提取物和酸枣仁提取物复方制剂及其制备方法和应用 - Google Patents
乌梅提取物和酸枣仁提取物复方制剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN101596246A CN101596246A CNA2009100884745A CN200910088474A CN101596246A CN 101596246 A CN101596246 A CN 101596246A CN A2009100884745 A CNA2009100884745 A CN A2009100884745A CN 200910088474 A CN200910088474 A CN 200910088474A CN 101596246 A CN101596246 A CN 101596246A
- Authority
- CN
- China
- Prior art keywords
- ziziphi spinosae
- semen ziziphi
- fructus mume
- extract
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 92
- 239000000284 extract Substances 0.000 title claims abstract description 86
- 238000002360 preparation method Methods 0.000 title claims abstract description 55
- 240000008866 Ziziphus nummularia Species 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 76
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 70
- 239000007788 liquid Substances 0.000 claims abstract description 70
- 239000003814 drug Substances 0.000 claims abstract description 53
- 241000700605 Viruses Species 0.000 claims abstract description 34
- 244000144977 poultry Species 0.000 claims abstract description 22
- 201000010099 disease Diseases 0.000 claims abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 16
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000011282 treatment Methods 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 11
- 244000144972 livestock Species 0.000 claims abstract description 8
- 239000007924 injection Substances 0.000 claims abstract description 7
- 238000002347 injection Methods 0.000 claims abstract description 7
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 6
- 239000002671 adjuvant Substances 0.000 claims abstract description 5
- 230000002265 prevention Effects 0.000 claims abstract description 5
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract description 4
- 230000008569 process Effects 0.000 claims abstract description 3
- 241000287828 Gallus gallus Species 0.000 claims description 81
- 239000000243 solution Substances 0.000 claims description 37
- 241000204031 Mycoplasma Species 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 15
- 230000037396 body weight Effects 0.000 claims description 15
- 241000271566 Aves Species 0.000 claims description 13
- 206010064097 avian influenza Diseases 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 208000027312 Bursal disease Diseases 0.000 claims description 8
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- 239000003208 petroleum Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 230000003203 everyday effect Effects 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000702626 Infectious bursal disease virus Species 0.000 claims description 3
- 238000005238 degreasing Methods 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000013599 spices Nutrition 0.000 claims description 3
- 241000712461 unidentified influenza virus Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000009472 formulation Methods 0.000 abstract description 4
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 230000004224 protection Effects 0.000 abstract description 2
- 238000002386 leaching Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 77
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 72
- 235000013330 chicken meat Nutrition 0.000 description 68
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 230000006378 damage Effects 0.000 description 24
- 229940079593 drug Drugs 0.000 description 24
- 235000019786 weight gain Nutrition 0.000 description 22
- SQHQDXGIJPHZRZ-AAWDLAKASA-N Jujuboside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)CO2)O)[C@@H](O)CO[C@H]1O[C@@H]1C(C)(C)[C@H](CC[C@@]2(C)[C@@]34C[C@]5([C@H]([C@@](C[C@@H](O5)C=C)(C)O)[C@H]4CC[C@H]42)OC3)[C@]4(C)CC1 SQHQDXGIJPHZRZ-AAWDLAKASA-N 0.000 description 21
- KVKRFLVYJLIZFD-OPGZLHQPSA-N jujuboside A Natural products C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC[C@@H]6[C@H]7[C@](C)(O)C[C@@H](O[C@@]78C[C@@]56CO8)C=C(C)C)C3(C)C)OC[C@H](O)[C@@H]2O[C@@H]9O[C@H](CO[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10O)[C@@H](O)[C@H](O)[C@H]9O[C@@H]%11OC[C@@H](O)[C@H](O)[C@H]%11O)[C@H](O)[C@H](O)[C@H]1O KVKRFLVYJLIZFD-OPGZLHQPSA-N 0.000 description 21
- QCLBRNPQMDEDIM-UHFFFAOYSA-N jujuboside C Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(COC3C(C(O)C(O)C(CO)O3)O)O2)O)C(O)COC1OC1C(C)(C)C(CCC2(C)C34CC5(C(C(CC(O5)C=C(C)C)(C)O)C4CCC42)OC3)C4(C)CC1 QCLBRNPQMDEDIM-UHFFFAOYSA-N 0.000 description 21
- 230000004584 weight gain Effects 0.000 description 20
- 235000013594 poultry meat Nutrition 0.000 description 18
- 241000588724 Escherichia coli Species 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 15
- 208000015181 infectious disease Diseases 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 208000032843 Hemorrhage Diseases 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- 231100000915 pathological change Toxicity 0.000 description 11
- 230000036285 pathological change Effects 0.000 description 11
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 11
- 229930003935 flavonoid Natural products 0.000 description 10
- 150000002215 flavonoids Chemical class 0.000 description 10
- 235000017173 flavonoids Nutrition 0.000 description 10
- 241001061264 Astragalus Species 0.000 description 9
- 235000006533 astragalus Nutrition 0.000 description 9
- 235000021053 average weight gain Nutrition 0.000 description 9
- 210000001669 bursa of fabricius Anatomy 0.000 description 9
- 150000004676 glycans Chemical class 0.000 description 9
- 238000007689 inspection Methods 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- 210000004233 talus Anatomy 0.000 description 9
- 239000004182 Tylosin Substances 0.000 description 8
- 229930194936 Tylosin Natural products 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 229960004059 tylosin Drugs 0.000 description 8
- 235000019375 tylosin Nutrition 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- RANQPHKSRUUPKK-UHFFFAOYSA-N 3-O-[alpha-L-arabinofuranosyl-(1->2)-O-{beta-D-glucopyranosyl-(1->3)}-(alpha-L-arabinopyranosyl)]jujubogenin Natural products CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(CO)C(O)C6O)C(C)(C)C5CCC4(C)C33COC2(C3)O1 RANQPHKSRUUPKK-UHFFFAOYSA-N 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 229930192286 jujuboside Natural products 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 208000018569 Respiratory Tract disease Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 210000002976 pectoralis muscle Anatomy 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 241001529453 unidentified herpesvirus Species 0.000 description 3
- 239000000273 veterinary drug Substances 0.000 description 3
- 150000004345 1,2-dihydroxyanthraquinones Chemical class 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 241001430197 Mollicutes Species 0.000 description 2
- 208000021642 Muscular disease Diseases 0.000 description 2
- 201000009623 Myopathy Diseases 0.000 description 2
- 235000011158 Prunus mume Nutrition 0.000 description 2
- 244000018795 Prunus mume Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- UBAXRAHSPKWNCX-UHFFFAOYSA-N diallyl trisulfide Chemical compound C=CCSSSCC=C UBAXRAHSPKWNCX-UHFFFAOYSA-N 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229930182493 triterpene saponin Natural products 0.000 description 2
- 230000009441 vascular protection Effects 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 201000002045 Ancylostomiasis Diseases 0.000 description 1
- 208000033211 Ankylostomiasis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020376 Hookworm infection Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000222065 Lycoperdon Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001148547 Mycoplasma gallinarum Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010071301 Perihepatitis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241000768494 Polymorphum Species 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- WMPXPUYPYQKQCX-UHFFFAOYSA-N Sulfamonomethoxine Chemical compound C1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 WMPXPUYPYQKQCX-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229930191701 arteannuin Natural products 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- RMKCQUWJDRTEHE-UHFFFAOYSA-N diallyl tetrasulfane Natural products C=CCSSSSCC=C RMKCQUWJDRTEHE-UHFFFAOYSA-N 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- -1 drying Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000021238 nutrient digestion Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000036178 pleiotropy Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229950003874 sulfamonomethoxine Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 206010047470 viral myocarditis Diseases 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100884745A CN101596246B (zh) | 2009-07-02 | 2009-07-02 | 乌梅提取物和酸枣仁提取物复方制剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100884745A CN101596246B (zh) | 2009-07-02 | 2009-07-02 | 乌梅提取物和酸枣仁提取物复方制剂及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101596246A true CN101596246A (zh) | 2009-12-09 |
CN101596246B CN101596246B (zh) | 2011-10-26 |
Family
ID=41417964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100884745A Expired - Fee Related CN101596246B (zh) | 2009-07-02 | 2009-07-02 | 乌梅提取物和酸枣仁提取物复方制剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101596246B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102119977A (zh) * | 2011-03-03 | 2011-07-13 | 天津瑞贝特科技发展有限公司 | 治疗奶牛乳房炎的中药灌注液及其制备方法 |
CN103237556A (zh) * | 2010-10-04 | 2013-08-07 | 韩国韩医学研究院 | 包含乌梅提取物的用于预防或治疗痴呆的组合物 |
CN103272018A (zh) * | 2013-05-10 | 2013-09-04 | 华南理工大学 | 酸枣仁安神催眠活性皂苷组分及其分离纯化方法与应用 |
CN107667939A (zh) * | 2017-11-17 | 2018-02-09 | 金陵科技学院 | 使用克氏原螯虾验证植物提取液细菌的抑菌活性的方法 |
CN110484369A (zh) * | 2019-08-06 | 2019-11-22 | 云南中烟新材料科技有限公司 | 一种基于提升乌梅提取率制备烟用香料的方法 |
CN110584035A (zh) * | 2019-09-29 | 2019-12-20 | 厦门市养真保健食品有限公司 | 一种复方酸枣仁乌梅颗粒及制备方法 |
CN112098568A (zh) * | 2019-06-17 | 2020-12-18 | 国药集团同济堂(贵州)制药有限公司 | 一种乌梅提取物的制备方法及其质量检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104039A (zh) * | 1993-12-22 | 1995-06-28 | 黄明和 | 饲料程际添加剂 |
CN1085055C (zh) * | 1999-07-06 | 2002-05-22 | 付光全 | 纯中药饲料添加剂的配制方法 |
CN100355368C (zh) * | 2005-01-11 | 2007-12-19 | 贵阳中医学院 | 具有增强免疫和对辐射危害有保护功能的保健品及其制备方法 |
-
2009
- 2009-07-02 CN CN2009100884745A patent/CN101596246B/zh not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103237556A (zh) * | 2010-10-04 | 2013-08-07 | 韩国韩医学研究院 | 包含乌梅提取物的用于预防或治疗痴呆的组合物 |
CN103237556B (zh) * | 2010-10-04 | 2016-03-16 | 韩国韩医学研究院 | 包含乌梅提取物的用于预防或治疗痴呆的组合物 |
US9814749B2 (en) | 2010-10-04 | 2017-11-14 | Korea Institute Of Oriental Medicine | Composition for preventing or treating dementia containing prunus mume extract |
CN102119977A (zh) * | 2011-03-03 | 2011-07-13 | 天津瑞贝特科技发展有限公司 | 治疗奶牛乳房炎的中药灌注液及其制备方法 |
CN102119977B (zh) * | 2011-03-03 | 2011-12-28 | 天津瑞贝特科技发展有限公司 | 治疗奶牛乳房炎的中药灌注液及其制备方法 |
CN103272018A (zh) * | 2013-05-10 | 2013-09-04 | 华南理工大学 | 酸枣仁安神催眠活性皂苷组分及其分离纯化方法与应用 |
CN107667939A (zh) * | 2017-11-17 | 2018-02-09 | 金陵科技学院 | 使用克氏原螯虾验证植物提取液细菌的抑菌活性的方法 |
CN112098568A (zh) * | 2019-06-17 | 2020-12-18 | 国药集团同济堂(贵州)制药有限公司 | 一种乌梅提取物的制备方法及其质量检测方法 |
CN110484369A (zh) * | 2019-08-06 | 2019-11-22 | 云南中烟新材料科技有限公司 | 一种基于提升乌梅提取率制备烟用香料的方法 |
CN110584035A (zh) * | 2019-09-29 | 2019-12-20 | 厦门市养真保健食品有限公司 | 一种复方酸枣仁乌梅颗粒及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101596246B (zh) | 2011-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101596246B (zh) | 乌梅提取物和酸枣仁提取物复方制剂及其制备方法和应用 | |
CN100431581C (zh) | 治疗禽流感的中药组合物、制备方法及其用途 | |
CN101455736B (zh) | 一种酸枣仁提取物的应用 | |
Wei et al. | Effects of Taishan Pinus massoniana pollen polysaccharide on immune response of rabbit haemorrhagic disease tissue inactivated vaccine and on production performance of Rex rabbits | |
CN100431596C (zh) | 治疗禽流感的药物组合物、制备方法及其用途 | |
CN102274314A (zh) | 常青球虫散及其制备方法 | |
CN101780153B (zh) | 一种猪用中药组合物及其制备方法和应用 | |
CN101317904B (zh) | 乌梅提取物在制备抗畜禽病毒药物中的用途 | |
CN103860616B (zh) | 刺五加提取物及其制备与应用 | |
CN102872307A (zh) | 一种防治家禽病毒类疾病的中药口服液及其制备方法 | |
CN102670694B (zh) | 一种治疗猪伪狂犬病的中药组合物及其制备方法和应用 | |
CN103768157A (zh) | 一种兽用抗病毒中药紫芪泡腾颗粒药物及其制备方法 | |
CN101926861A (zh) | 用于增强非特异性免疫功能的中药兽用药的制备方法 | |
CN102813713B (zh) | 一种绵马贯众山楂组合物、其制备方法与应用 | |
CN101912452A (zh) | 用于增强非特异性免疫功能的兽用中药组合物及其应用 | |
CN101804112B (zh) | 贯众乌梅中药组合物制备方法及应用 | |
CN103417653B (zh) | 一种治疗球虫的兽用复方纯中药及其口服液的制备方法 | |
CN104367673B (zh) | 一种治疗鸡球虫的中药组合物 | |
CN102600120B (zh) | 肉桂酸在制备防治畜禽病毒感染的药物中的应用 | |
CN106266686A (zh) | 提高家禽免疫力的中药制剂及其应用 | |
CN101982188B (zh) | 唐古特青兰在制备治疗畜禽病毒性传染病的药物中的应用 | |
CN102697800B (zh) | 繁缕多糖组合物及其在制备抗病毒药物中的应用 | |
CN1506092A (zh) | 一种治疗腹泻的香薷提取物胶囊制剂及其制备方法 | |
CN103356717B (zh) | 绵马贯众提取物及其在制备防治病毒病药物中的用途 | |
CN101549011B (zh) | 垂花香薷在制备治疗畜禽传染病的药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HE CHENG Free format text: FORMER OWNER: BEIJING ZHONGNONG PUKANG BIOTECHNOLOGY CO., LTD. Effective date: 20131125 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 100193 HAIDIAN, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131125 Address after: 100193 School of veterinary medicine, China Agricultural University, 2 West Old Summer Palace Road, Beijing, Haidian District Patentee after: He Cheng Address before: 100083 Beijing City College of Haidian District No. 11 ritin Baoyuan apartment building A2 501-2 Patentee before: Beijing Zhongnong Pukang Biotechnology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111026 |